These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 34404447

  • 1. Humeral metastasis as the only recurrence of a 5-year resected gastrointestinal stromal tumor: a case report.
    Braunstein C, Sirveaux F, Kalbacher E, Aubry S, Delroeux D, Hubert P, Marie B, Meynard G, Mihai I, Chaigneau L.
    J Med Case Rep; 2021 Aug 18; 15(1):428. PubMed ID: 34404447
    [Abstract] [Full Text] [Related]

  • 2. Solitary peritoneal metastasis of gastrointestinal stromal tumor: A case report.
    Sugiyama Y, Shimbara K, Sasaki M, Kouyama M, Tazaki T, Takahashi S, Nakamitsu A.
    World J Gastroenterol; 2020 Sep 28; 26(36):5527-5533. PubMed ID: 33024403
    [Abstract] [Full Text] [Related]

  • 3. [A Case of Gastrointestinal Stromal Tumor Re-Resected Ten Years after the Resection of Its Recurrence].
    Aida T, Shiobara M, Wakatsuki K, Ogasawara T, Suda K, Miyazawa K, Miyoshi T, Sato S, Yoshioka S, Yamazaki K.
    Gan To Kagaku Ryoho; 2019 Dec 28; 46(13):1943-1944. PubMed ID: 32157020
    [Abstract] [Full Text] [Related]

  • 4. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
    Zhu J, Yang Y, Zhou L, Jiang M, Hou M.
    BMC Cancer; 2010 May 13; 10():199. PubMed ID: 20465813
    [Abstract] [Full Text] [Related]

  • 5. [A Case of Rectal Gastrointestinal Stromal Tumor(GIST)with Long-Term Survival Treated with Multidisciplinary Therapy].
    Tendo M, Hori T, Iimori N, Deguchi S, Sakimura C, Masuda G, Nakao S, Nakata B, Ohira M, Ishikawa T, Hirakawa K.
    Gan To Kagaku Ryoho; 2018 Dec 13; 45(13):2288-2290. PubMed ID: 30692440
    [Abstract] [Full Text] [Related]

  • 6. Budgetary impact of treatment with adjuvant imatinib for 1 year following surgical resection of Kit-positive localized gastrointestinal stromal tumors.
    Rubin JL, Taylor DC, Sanon M, Coombs JH, Bollu VK.
    J Manag Care Pharm; 2010 Sep 13; 16(7):482-91. PubMed ID: 20726677
    [Abstract] [Full Text] [Related]

  • 7. [Low-Dose and Interval Administration of Imatinib in a Patient with Liver Metastasis of the Gastrointestinal Stromal Tumor of the Stomach - A Case Report].
    Morinaga N, Saito H, Komine C, Matsumoto A, Katoh T, Tanaka N, Nakazato K, Nakamura T, Shitara Y, Ishizaki M.
    Gan To Kagaku Ryoho; 2017 Feb 13; 44(2):161-164. PubMed ID: 28223675
    [Abstract] [Full Text] [Related]

  • 8. Gastric Gastrointestinal Stromal Tumor with Repeated Recurrence at the Anastomosis Site in a Very Elderly Patient.
    Kim HJ, Park JY, Kim BJ, Kim JG, Kim HS, Park JM.
    Korean J Gastroenterol; 2020 Oct 25; 76(4):206-210. PubMed ID: 33100316
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
    Raut CP, Espat NJ, Maki RG, Araujo DM, Trent J, Williams TF, Purkayastha DD, DeMatteo RP.
    JAMA Oncol; 2018 Dec 01; 4(12):e184060. PubMed ID: 30383140
    [Abstract] [Full Text] [Related]

  • 10. Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China.
    Shi YN, Li Y, Wang LP, Wang ZH, Liang XB, Liang H, Zhang L, Li B, Fan LQ, Zhao Q, Ma ZX, Zhao XF, Zhang ZD, Liu Y, Tan BB, Wang D, Wang LL, Hao YJ, Jia N.
    Medicine (Baltimore); 2017 Nov 01; 96(46):e8240. PubMed ID: 29145240
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.
    Kimura T, Togawa T, Onishi K, Iida A, Sato Y, Goi T.
    J Investig Med High Impact Case Rep; 2020 Nov 01; 8():2324709620970736. PubMed ID: 33228387
    [Abstract] [Full Text] [Related]

  • 12. Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate.
    Colović R, Micev M, Matić S, Colović N, Grubor N, Atkinson HD.
    Vojnosanit Pregl; 2013 Feb 01; 70(2):225-8. PubMed ID: 23607193
    [Abstract] [Full Text] [Related]

  • 13. [A Case of GIST of Stomach with Peritoneal Dissemination-Long-Term Survival with Imatinib and Surgical Resection].
    Nakata K, Masuzawa T, Katsuyama S, Sugimura K, Ikeshima R, Kawai K, Hiraki M, Shinke G, Katsura Y, Ohmura Y, Hata T, Takeda Y, Murata K.
    Gan To Kagaku Ryoho; 2022 Dec 01; 49(13):1429-1430. PubMed ID: 36733091
    [Abstract] [Full Text] [Related]

  • 14. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.
    Keung EZ, Fairweather M, Raut CP.
    Curr Treat Options Oncol; 2016 Feb 01; 17(2):8. PubMed ID: 26820287
    [Abstract] [Full Text] [Related]

  • 15. Imatinib and nutritional support can make successful treatment for a case of huge liver metastasis of duodenal gastrointestinal stromal tumor that initially showed jaundice and cachexia.
    Tateyama Y, Naganuma A, Suzuki Y, Masuda T, Uehara S, Hoshino T, Yasuoka H, Kudo T, Ogawa Y, Ogawa T, Tateno K, Ishii N, Araki K, Harimoto N, Shirabe K, Kakizaki S.
    Clin J Gastroenterol; 2021 Apr 01; 14(2):570-576. PubMed ID: 33507488
    [Abstract] [Full Text] [Related]

  • 16. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF, Perry CM.
    Drugs; 2003 Apr 01; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [Abstract] [Full Text] [Related]

  • 17. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.
    Anticancer Drugs; 2008 Jul 01; 19(6):607-12. PubMed ID: 18525320
    [Abstract] [Full Text] [Related]

  • 18. Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report.
    Fukuda S, Fujiwara Y, Wakasa T, Kitani K, Tsujie M, Yukawa M, Ohta Y, Inoue M.
    J Med Case Rep; 2017 Feb 07; 11(1):33. PubMed ID: 28166823
    [Abstract] [Full Text] [Related]

  • 19. Synchronous Large Gastrointestinal Stromal Tumor and Adenocarcinoma in the Stomach Treated with Imatinib Mesylate Followed by Total Gastrectomy.
    Namikawa T, Munekage E, Munekage M, Maeda M, Yatabe T, Kitagawa H, Sakamoto K, Obatake M, Kobayashi M, Hanazaki K.
    Anticancer Res; 2016 Apr 07; 36(4):1855-9. PubMed ID: 27069170
    [Abstract] [Full Text] [Related]

  • 20. [Significance of circulating tumor cell monitoring in targeted therapy for gastrointestinal stromal tumors].
    Fan JB, Zhi XF, Chen SS, Zhu JW.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep 25; 24(9):789-795. PubMed ID: 34530560
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.